NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,086 | -62.8% | 200 | 0.0% | 0.00% | – |
Q2 2023 | $8,291 | -73.8% | 200 | -62.0% | 0.00% | – |
Q1 2023 | $31,702 | -18.7% | 527 | -0.9% | 0.00% | – |
Q4 2022 | $38,996 | -0.0% | 532 | +2.9% | 0.00% | – |
Q3 2022 | $39,000 | +8.3% | 517 | 0.0% | 0.00% | – |
Q2 2022 | $36,000 | -10.0% | 517 | +7.0% | 0.00% | – |
Q1 2022 | $40,000 | +11.1% | 483 | 0.0% | 0.00% | – |
Q4 2021 | $36,000 | – | 483 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |